We deliver the only automated, end-to-end genomic surveillance platform to proactively detect infection transmission.
NGD Infection Prevention uses real-time genomic sequencing to detect transmission events early—so infection prevention teams can act faster, reduce harm, and lower costs.
↓
The Solution
Detect transmission earlier.
Act faster.
NGD Infection Prevention gives you real-time visibility into how infections spread within your hospital.
By combining automated sequencing (NGD200) with advanced analytics (NGD EpiAssist), you can:
Identify transmission events as they happen
Track infection pathways between patients and wards
Intervene earlier to prevent outbreaks
Reduce hospital-acquired infections and associated costs
NGD’s Vanguard Solution: NGD200 & NGD EpiAssist
How It Works
From samples to actionable insights in one workflow.
Frequently Asked Questions
-
Genomic sequencing identifies genetic similarities between pathogens, allowing detection of related cases and transmission pathways.
-
Significantly faster than traditional methods - around 24 hours.
-
No, it enhances them by adding a layer of high-resolution insight.
-
NGD integrates into existing lab and infection control workflows with minimal disruption.
See how NGD can transform your infection prevention strategy.
Industry Testimonials
“It is increasingly clear that WGS is going to be central to clinical infectious disease practice as well as to hospital infection prevention, and NGD is one of the leaders of this transformation.”
Dr. Linoj Samuel
Division Head of the Clinical Microbiology Laboratory for Henry Ford Health in Detroit Michigan
Next Gen Diagnostics’ system was put in place at Addenbrooke’s between 2018-2019, and helped both catch transmission and curtail outbreaks, [...] sparing patients. We believe this is the future of infection control.
Spokesperson
Addenbrooke’s Hospital, Cambridge UK
“We know that utilization of the unsurpassable depth of information available in WGS is increasingly the future of microbiology diagnostics and infection control, and we look forward to this timely and compelling opportunity to work with NGD on this project, the first of its kind in Israel.”
Dr. Sharon Amit Medical Director of Clinical Microbiology Laboratory at Sheba
Latest News
